CZ VACCINES S.A.U. – Trademark Portfolio
Entity Type: 85
CZ VACCINES S.A.U. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ZENDAL, BLUEVAC, and NEOLEISH. The owner is based in PORRIÑO (PONTEVEDRA).
POLÍGONO INDUSTRIAL TORNEIROS
PORRIÑO (PONTEVEDRA) 36400 , ES
Showing of trademarks Trademarks
Trademark Classifications
CZ VACCINES S.A.U.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CZ VACCINES S.A.U. have?
CZ VACCINES S.A.U. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does CZ VACCINES S.A.U. file in?
CZ VACCINES S.A.U. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CZ VACCINES S.A.U.'s most well-known trademarks?
CZ VACCINES S.A.U.'s registered trademark portfolio includes well-known marks such as ZENDAL, BLUEVAC, and NEOLEISH. These are among 3 currently registered trademarks in the portfolio.
What is CZ VACCINES S.A.U.'s trademark registration success rate?
CZ VACCINES S.A.U. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.